Viewing Study NCT01317927


Ignite Creation Date: 2026-03-26 @ 3:21 PM
Ignite Modification Date: 2026-04-08 @ 1:13 PM
Study NCT ID: NCT01317927
Status: COMPLETED
Last Update Posted: 2015-09-23
First Post: 2011-03-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Sponsor: Spectrum Pharmaceuticals, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module